Page last updated: 2024-09-05

clasto-lactacystin beta-lactone and deferoxamine

clasto-lactacystin beta-lactone has been researched along with deferoxamine in 1 studies

Compound Research Comparison

Studies
(clasto-lactacystin beta-lactone)
Trials
(clasto-lactacystin beta-lactone)
Recent Studies (post-2010)
(clasto-lactacystin beta-lactone)
Studies
(deferoxamine)
Trials
(deferoxamine)
Recent Studies (post-2010) (deferoxamine)
850156,7032401,266

Protein Interaction Comparison

ProteinTaxonomyclasto-lactacystin beta-lactone (IC50)deferoxamine (IC50)
Lysine-specific demethylase 4AHomo sapiens (human)3.275
Deoxyhypusine hydroxylaseHomo sapiens (human)5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukuchi, K; Gomi, K; Maruyama, H; Takagi, Y1

Other Studies

1 other study(ies) available for clasto-lactacystin beta-lactone and deferoxamine

ArticleYear
Direct proteasome inhibition by clasto-lactacystin beta-lactone permits the detection of ubiquitinated p21(waf1) in ML-1 cells.
    Biochimica et biophysica acta, 1999, Aug-12, Volume: 1451, Issue:1

    Topics: Acetylcysteine; Antibodies; Blotting, Western; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cysteine Endopeptidases; Deferoxamine; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Humans; Lactones; Multienzyme Complexes; Proteasome Endopeptidase Complex; Tumor Cells, Cultured; Ubiquitins

1999